Here’s Why Pharmaceutical Companies Raise Their Prices So Much

Yes, I’ve ranted about healthcare prices before. On more than one occasion. But I have a new rant for you. It’s not about the high price of new drugs It’s not about a couple pharmo-bro CEOs hiking prices of generic medications by 4 or 5,000% It’s about brand name drugs already on the market, that, […]

Read More
Your Risk Of Prostate Cancer Just Dropped Precipitously. Here's Why

Most men diagnosed with prostate cancer don’t die of the disease. Between 2011 and 2015, 112.6 per 100,000 men per year were diagnosed with prostate cancer in the U.S., but only 19.5 per 100,000 men per year died of the disease over that same period of time. That is still far too many deaths. But the […]

Read More
The Question Isn't Whether We Are Overdiagnosing Cancer, But How Much

Medical experts now agree that as a result of aggressive screening programs, we have an epidemic of cancer overdiagnosis in the United States. With mammograms finding tiny cancers and PSA tests discovering unpalpable prostate cancers, we are now unearthing some cancers too early for our own good. What do experts mean by “overdiagnosis,” you ask? […]

Read More
If You Look for Cancer, You'll Find It

What would you like first: the good news or the bad news? Let me start with the bad. Life expectancy among patients in the U.S. with thyroid cancer lags behind that in Korea. In fact, the vast majority of patients diagnosed with thyroid cancer in Korea are cured of that illness, a statement I can’t […]

Read More
Millions To Be Made On…Generic Drugs?

It is well accepted among health economics wonks that the lion’s share of pharmaceutical company profits come when these companies hold exclusive rights to their products. Once their blockbuster pills go “generic,” competitors enter the marketplace and profits plummet. Consider captopril, a groundbreaking heart failure medication introduced in the early 80s by Bristol-Myers Squibb under […]

Read More

PeterUbel